MDGL Madrigal Pharmaceuticals Inc

USD 267.04 8.23 3.179939
Icon

Madrigal Pharmaceuticals Inc (MDGL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 267.04

+8.23 (+3.18)%

USD 5.12B

0.44M

USD 369.79(+38.48%)

USD 0.00 (-100.00%)

Icon

MDGL

Madrigal Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 267.04
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.12B

USD 0.00 (-100.00%)

USD 267.04

Madrigal Pharmaceuticals Inc (MDGL) Stock Forecast

Show ratings and price targets of :
USD 369.79
(+38.48%)

Based on the Madrigal Pharmaceuticals Inc stock forecast from 11 analysts, the average analyst target price for Madrigal Pharmaceuticals Inc is USD 369.79 over the next 12 months. Madrigal Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Madrigal Pharmaceuticals Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Madrigal Pharmaceuticals Inc’s stock price was USD 267.04. Madrigal Pharmaceuticals Inc’s stock price has changed by +4.61% over the past week, +5.04% over the past month and +10.90% over the last year.

No recent analyst target price found for Madrigal Pharmaceuticals Inc
No recent average analyst rating found for Madrigal Pharmaceuticals Inc

Company Overview Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone recept...Read More

Four Tower Bridge, West Conshohocken, PA, United States, 19428

376

December

USD

USA

Adjusted Closing Price for Madrigal Pharmaceuticals Inc (MDGL)

Loading...

Unadjusted Closing Price for Madrigal Pharmaceuticals Inc (MDGL)

Loading...

Share Trading Volume for Madrigal Pharmaceuticals Inc Shares

Loading...

Compare Performance of Madrigal Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for MDGL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Madrigal Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S +0.35 (+0.27%) USD554.45B 46.01 4.80

ETFs Containing MDGL

Symbol Name MDGL's Weight Expense Ratio Price(Change) Market Cap
ULTY
YieldMax Ultra Option Inc.. 5.86 % 1.14 % +0.07 (+0.38%) USD2.42M

Frequently Asked Questions About Madrigal Pharmaceuticals Inc (MDGL) Stock

Based on ratings from 11 analysts Madrigal Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 18 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on MDGL's stock to indicate if its a good dividend stock.

Based on targets from 11 analysts, the average taret price for MDGL is USD 369.79 over the next 12 months. The maximum analyst target price is USD 565 while the minimum anlayst target price is USD 270.

Unfortunately we do not have enough data on MDGL's stock to indicate if its overvalued.

The last closing price of MDGL's stock was USD 267.04.

The most recent market capitalization for MDGL is USD 5.12B.

Based on targets from 11 analysts, the average taret price for MDGL is projected at USD 369.79 over the next 12 months. This means that MDGL's stock price may go up by +38.48% over the next 12 months.

Following are ETFs with the highest allocation to Madrigal Pharmaceuticals Inc's stock :

ULTY

As per our most recent records Madrigal Pharmaceuticals Inc has 376 Employees.

Madrigal Pharmaceuticals Inc's registered address is Four Tower Bridge, West Conshohocken, PA, United States, 19428. You can get more information about it from Madrigal Pharmaceuticals Inc's website at https://www.madrigalpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...